|
Mar 27
|
Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
|
|
Mar 27
|
IBD Stock Of The Day Eli Lilly Jumps Early Entry As Viking Charges Obesity Space
|
|
Mar 26
|
Viking Surges After Weight-Loss Pill — A Rival To Novo, Lilly — Beats Expectations In Just 28 Days
|
|
Mar 26
|
Viking Therapeutics stock rises on positive Phase 1 weight-loss pill data
|
|
Mar 26
|
Why Viking Therapeutics Stock Is Skyrocketing Today
|
|
Mar 26
|
Viking Therapeutics stock surges on weight loss pill data
|
|
Mar 26
|
Viking Therapeutics Posts Promising Early Weight-Loss Data as Cost Worries Escalate
|
|
Mar 26
|
Viking Therapeutics: Buy, Sell, or Hold?
|
|
Mar 26
|
Viking stays in obesity drug race with early data for weight loss pill
|
|
Mar 26
|
Viking Therapeutics' weight-loss tablet shows promise in small study
|
|
Mar 26
|
Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735
|
|
Mar 26
|
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
|
|
Mar 26
|
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
|
|
Mar 25
|
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
|
|
Mar 24
|
Is Viking Therapeutics Stock a Millionaire Maker?
|
|
Mar 23
|
Where Will Viking Therapeutics Stock Be in 10 Years?
|
|
Mar 22
|
Could Viking Therapeutics Become the Next Eli Lilly?
|
|
Mar 21
|
Viking Therapeutics Stock Has 55% Upside, According to 1 Wall Street Analyst
|
|
Mar 20
|
2 Incredible Growth Stocks to Buy Right Now
|
|
Mar 20
|
Feisty Rivals Take On Eli Lilly, Novo Nordisk On Weight Loss
|